DCK Back

deoxycytidine kinase

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of DCK
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

Community Annotation of DCK Add / Edit DCK: Annotations

No community annotations yet for DCK.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

DCK is highly significantly mutated in
(none)
DCK is significantly mutated in
(none)
DCK is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for DCK